NPPB and heart failure: In NCT02278276, the oral prodrug SG1002, which releases polysulfides in a sustained manner, completed a phase II in patients with heart failure: for 12 weeks it stably raised plasma H2S and nitrite and was associated with decreases in BNP and systolic blood pressure without serious adverse events, supporting the safety of the approach [18].